Zheng Huang Selected Research

Circular RNA

1/2021	Circular RNA ITCH promotes extracellular matrix degradation via activating Wnt/β-catenin signaling in intervertebral disc degeneration.
3/2018	Identification of differentially expressed circular RNAs during TGF-ß1-induced endothelial-to-mesenchymal transition in rat coronary artery endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Huang Research Topics

Disease

53	Neoplasms (Cancer) 05/2024 - 08/2002
12	Inflammation (Inflammations) 03/2024 - 09/2013
10	Infections 01/2021 - 07/2011
9	Port-Wine Stain (Nevus Flammeus) 04/2024 - 03/2006
9	Pain (Aches) 01/2023 - 02/2013
8	Necrosis 02/2023 - 10/2002
8	Rheumatoid Arthritis 01/2023 - 02/2011
7	Fibrosis (Cirrhosis) 05/2023 - 06/2004
6	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2020
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 02/2003
6	Nasopharyngeal Carcinoma 09/2020 - 03/2006
5	Hypertension (High Blood Pressure) 01/2024 - 01/2018
5	Carcinogenesis 01/2019 - 02/2003
5	Condylomata Acuminata (Genital Wart) 05/2012 - 03/2006
4	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 06/2019
4	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2023
4	Phototoxic Dermatitis (Phototoxicity) 02/2024 - 12/2012
4	Hypoxia (Hypoxemia) 09/2023 - 08/2002
4	Moyamoya Disease (Moya-Moya Disease) 01/2023 - 02/2011
4	Glioma (Gliomas) 12/2022 - 09/2008
4	Myocardial Infarction 10/2021 - 01/2013
4	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 01/2018
4	Ischemia 01/2021 - 10/2013
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2006
4	Liver Neoplasms (Liver Cancer) 02/2017 - 03/2006
4	Acne Vulgaris 09/2016 - 03/2010
4	Carcinoma (Carcinomatosis) 01/2015 - 08/2002
4	Prostatic Neoplasms (Prostate Cancer) 12/2007 - 10/2002
3	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 03/2018
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2023 - 01/2022
3	Pathologic Processes 08/2023 - 01/2021
3	Ovarian Neoplasms (Ovarian Cancer) 07/2023 - 01/2016
3	Aneurysm (Aneurysms) 05/2023 - 08/2018
3	Cicatrix (Scar) 01/2022 - 12/2012
3	Lordosis 01/2022 - 02/2021
3	Heart Failure 01/2022 - 01/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 09/2013
3	Rupture 07/2021 - 11/2017
3	Myocardial Ischemia (Ischemic Heart Diseases) 07/2021 - 05/2005
3	Premature Birth (Birth, Premature) 01/2021 - 01/2017
3	Birth Weight (Birth Weights) 01/2021 - 01/2017
3	Diarrhea 11/2019 - 12/2011
3	Pregnancy Complications 10/2018 - 01/2017
3	Obesity 01/2012 - 03/2010
3	Chronic Obstructive Pulmonary Disease (COPD) 03/2006 - 08/2005
2	Endometrial Neoplasms (Endometrial Cancer) 05/2024 - 02/2024
2	Hyperuricemia 01/2024 - 01/2023
2	Non-alcoholic Fatty Liver Disease 11/2023 - 01/2023

Drug/Important Bio-Agent (IBA)

44	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2024 - 08/2002
15	Proteins (Proteins, Gene)FDA Link 09/2023 - 02/2003
14	AcidsIBA 02/2024 - 09/2007
9	Photosensitizing Agents (Photosensitizers)IBA 12/2022 - 10/2002
7	CateninsIBA 01/2023 - 05/2012
6	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2015
6	Therapeutic UsesIBA 02/2023 - 01/2006
6	Phosphodiesterase 4 InhibitorsIBA 01/2023 - 10/2002
5	Long Noncoding RNAIBA 04/2024 - 06/2019
5	CollagenIBA 02/2023 - 09/2013
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2008
5	Aminolevulinic Acid (Levulan)FDA Link 01/2017 - 12/2008
5	Stearoyl-CoA DesaturaseIBA 01/2012 - 03/2010
5	palladium-bacteriopheophorbideIBA 12/2007 - 10/2002
4	hematoporphyrin monomethyl etherIBA 04/2024 - 09/2010
4	protoporphyrin IXIBA 02/2024 - 09/2007
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2022
4	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2013
4	LigandsIBA 10/2021 - 10/2013
4	SolutionsIBA 02/2018 - 09/2007
4	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 01/2018 - 08/2002
4	CadmiumIBA 01/2018 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 12/2008
3	ProdrugsIBA 02/2024 - 10/2021
3	EnzymesIBA 01/2024 - 09/2014
3	Glutathione (Reduced Glutathione)IBA 01/2024 - 11/2020
3	LipidsIBA 12/2023 - 01/2006
3	salicylhydroxamic acid (SHAM)IBA 09/2023 - 01/2020
3	CytokinesIBA 05/2023 - 01/2006
3	MetalsIBA 09/2022 - 11/2013
3	Messenger RNA (mRNA)IBA 01/2016 - 02/2011
2	Immune Checkpoint InhibitorsIBA 05/2024 - 03/2024
2	Coloring Agents (Dyes)IBA 02/2024 - 01/2006
2	EstersIBA 02/2024 - 07/2017
2	Heme (Haem)IBA 02/2024 - 09/2014
2	Oxidoreductases (Dehydrogenase)IBA 01/2024 - 01/2021
2	Uric Acid (Urate)IBA 01/2024 - 01/2023
2	6-methyladenineIBA 11/2023 - 01/2023
2	16S Ribosomal RNAIBA 11/2023 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 03/2010
2	palmatineIBA 10/2023 - 12/2022
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2023 - 01/2022

Therapy/Procedure

46	Photochemotherapy (Photodynamic Therapy) 02/2024 - 08/2002
20	Therapeutics 01/2024 - 10/2002
8	Lasers (Laser) 04/2024 - 08/2002
5	Aftercare (After-Treatment) 01/2021 - 10/2011
4	Immunotherapy 03/2024 - 01/2006
3	Drug Therapy (Chemotherapy) 10/2023 - 04/2020
3	Acupuncture Therapy 09/2023 - 11/2020
3	Ischemic Postconditioning 01/2020 - 01/2020
3	Dye Lasers 12/2014 - 03/2008